Oncocyte Corp CEO William Annett's 2018 pay falls 22% to $926K
Oncocyte Corp reports 2018 executive compensation
By ExecPay News
Published: June 18, 2019
Oncocyte Corp reported fiscal year 2018 executive compensation information on June 18, 2019.
In 2018, three executives at Oncocyte Corp received on average a compensation package of $883K, a 36% increase compared to previous year.
Average pay of disclosed executives at Oncocyte Corp
William Annett, Chief Executive Officer, received $926K in total, which decreased by 22% compared to 2017. 43% of Annett's compensation, or $400K, was in salary. Annett also received $220K in bonus, $292K in option awards, as well as $14K in other compensation.
Mitchell Levine, Chief Financial Officer, received a compensation package of $873K, which increased by 39% compared to previous year. 41% of the compensation package, or $359K, was in option awards.
Lyndal K. Hesterberg, Chief Scientific Officer, earned $851K in 2018, a 184% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on June 18, 2019.